Mitochondrial Respiratory Defect Enhances Hepatoma Cell Invasiveness via STAT3/NFE2L1/STX12 Axis
Authors:
- Young-Kyoung LeeYLYoung-Kyoung Lee
- So Mee KwonSKSo Mee Kwon
- Eun-Beom LeeELEun-Beom Lee
- Gyeong-Hyeon KimGKGyeong-Hyeon Kim
- Seongki MinSMSeongki Min
- Sun-Mi HongSHSun-Mi Hong
- Hee-Jung WangHWHee-Jung Wang
- Dong Min LeeDLDong Min Lee
- Kyeong Sook ChoiKCKyeong Sook Choi
- Tae Jun ParkTPTae Jun Park
- Gyesoon YoonGYGyesoon Yoon
Open Access
Abstract
Mitochondrial respiratory defects have been implicated in cancer progression and metastasis, but how they control tumor cell aggressiveness remains unclear. Here, we demonstrate that a mitochondrial respiratory defect induces nuclear factor-erythroid 2 like 1 (NFE2L1) expression at the transcriptional level via reactive oxygen species (ROS)-mediated STAT3 activation. We identified syntaxin 12 (STX12) as an effective downstream target of NFE2L1 by performing cDNA microarray analysis after the overexpression and depletion of NFE2L1 in hepatoma cells. Bioinformatics analysis of The Cancer Genome Atlas Liver Hepatocellular carcinoma (TCGA-LIHC) open database (n = 371) also revealed a significant positive association (r = 0.3, p = 2.49 × 10−9) between NFE2L1 and STX12 expression. We further demonstrated that STX12 is upregulated through the ROS/STAT3/NFE2L1 axis and is a key downstream effector of NFE2L1 in modulating hepatoma cell invasiveness. In addition, gene enrichment analysis of TCGA-LIHC also showed that epithelial–mesenchymal transition (EMT)-related core genes are significantly upregulated in tumors co-expressing NFE2L1 and STX12. The positive association between NFE2L1 and STX12 expression was validated by immunohistochemistry of the hepatocellular carcinoma tissue array. Finally, higher EMT gene enrichment and worse overall survival (p = 0.043) were observed in the NFE2L1 and STX12 co-expression group with mitochondrial defect, as indicated by low NDUFA9 expression. Collectively, our results indicate that NFE2L1 is a key mitochondrial retrograde signaling-mediated primary gene product enhancing hepatoma cell invasiveness via STX12 expression and promoting liver cancer progression.Keywords
Funding Information
- National Research Foundation of Korea (2017M3A9B6061509, 2020R1C1C1007611, 2020M3A9D8037604, 2020R1A6A1A03043539)
This publication has 46 references indexed in Scilit:
- Mitochondrial Dysfunction: A Novel Potential Driver of Epithelial-to-Mesenchymal Transition in CancerFrontiers in Oncology, 2017
- Role of mitochondrial dysfunction in cancer progressionExperimental Biology and Medicine, 2016
- Mitochondrial dysfunction in cancer chemoresistanceBiochemical Pharmacology, 2014
- Mitochondrial dysfunction and cancer metastasisJournal of Bioenergetics and Biomembranes, 2012
- Lactate: A Metabolic Key Player in CancerCancer Research, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Why do cancers have high aerobic glycolysis?Nature Reviews Cancer, 2004
- Mitochondrial SignalingMolecular Cell, 2004
- Retrograde Ca2+ signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: a novel mode of inter‐organelle crosstalkThe EMBO Journal, 1999
- On the Origin of Cancer CellsScience, 1956